Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment., Onnockx, Sheela , Vaccines (Basel), 2023 Sep 01, Volume 11, Issue 9, (2023)

Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2, Baldo, Aline, Leunda Amaya, Willemarck Nicolas, and Pauwels Katia , Vaccines, Jan-05-2021, Volume 9, Issue 5, (2021)

GMO Regulatory Aspects of Novel Investigational Vaccine Candidates, Leunda, Amaya, and Pauwels Katia , Vaccines - the History and Future?, (2019)

Genome Editing in Agriculture: Methods, Applications, and Governance?A paper in the series on The Need for Agricultural Innovation to Sustainably Feed the World by 2050, Bogdanove, AJ, Donovan DM, Elorriaga E, Kuzma J, Pauwels Katia, Strauss S, and Voytas D , Council for Agricultural Science and Technology (CAST), 2018, Volume 60, Issue 60, (2018)

Annual polio report for the European Regional Certification Commission for the year 2015. National Certification Committee Belgium, Mendes, E, Pauwels Katia, and Sabbe Martine , 01/04/2016, Brussels, p.49, (2016)

Annual polio report for the European Regional Certification Commission for the year 2014. National Certification Committee Belgium., Mendes, E, Pauwels Katia, and Sabbe Martine , 1/4/2015, Number 39, Brussels, p.39, (2015)

Biosafety Recommendations on the Handling of Animal Cell Cultures, Herman, Philippe, and Pauwels Katia , Animal Cell Culture, 1/1/2015, Volume 9, Issue 22, Number 716, Switzerland, p.27, (2015)

GAP III - The WHO poliovirus containment policy : Implications and implementation in Belgium, Pauwels, Katia , Werkgroep vaccinatie, 19/3/2015, Issue Hogegezondheidsraad, (2015)

Next-generation sequencing as a tool for the molecular characterisation and risk assessment of genetically modified plants: Added value or not?, Pauwels, Katia, De Keersmaecker Sigrid C. J., De Schrijver Adinda, du Jardin P., Roosens Nancy, and Herman Philippe , Trends Food Sci. Technol., Volume 45, Issue 2, p.319 - 326, (2015)

Opinion on Synthetic Biology II - Risk assessment methodologies and safety aspects, Vermeire, T., Epstein M., Hartemann P., Proykova A., Rodriguez Farre E., L. Martinez Martinez, Fernandes T., Chaudhry K., Rastogi S. Chandra, Breitling R., et al. , 4/5/2015, Number 65, Luxembourg, p.65, (2015)

Engineering nucleases for gene targeting: safety and regulatory considerations., Pauwels, Katia, Podevin Nancy, Breyer Didier, Carroll Dana, and Herman Philippe , N Biotechnol, 2014 Jan 25, Volume 31, Issue 1, Number 27, p.18-27, (2014)

Opinion on  Synthetic Biology - I. Definition, Vermeire, T., Epstein M., Hartemann P., Proykova A., Rodriguez Farre E., L. Martinez Martinez, Fernandes T., Chaudhry K., Rastogi S. Chandra, Breitling R., et al. , 25/9/2014, Number 67, Luxembours, p.67, (2014)

Biosafety risk assessment and management of laboratory-derived influenza A (H5N1) viruses transmissible in ferrets, Baldo, Aline, Leunda Amaya, Do Thi Chuong Dai, Breyer Didier, Pauwels Katia, Welby Sarah, Van Vaerenbergh Bernadette, and Herman Philippe , Applied Biosafety, 3/2013, Volume 18, Issue 1, Number 17, (2013)

Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors., Goossens, Martine, Pauwels Katia, Willemarck Nicolas, and Breyer Didier , Curr Gene Ther, 2013 Dec, Volume 13, Issue 6, p.413-20, (2013)

Event report: SynBio Workshop (Paris 2012) - Risk assessment challenges of Synthetic Biology, Pauwels, Katia, Mampuys Ruth, Golstein Catherine, Breyer Didier, Herman Philippe, Kaspari M., Pagès J-C., Pfister Herbert, and Wilk Frank , J.Verbr.Lebensm., 0/0/2013, Volume 8, Number 226, p.215 - 226, (2013)

General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination., Baldo, Aline, van den Akker Eric, Bergmans Hans E., Lim Filip, and Pauwels Katia , Curr Gene Ther, 2013 Dec, Volume 13, Issue 6, Number 394, p.385-94, (2013)

Organisation of expertise for the risk evaluation of biosafety dossiers in Belgium, Pauwels, Katia , 14/5/2013, (2013)

Are 'Omics' contributing to the identification of unintended effects in genetically modified crops?2743, Pauwels, Katia , Biosafety, 15/2/2012, Volume 1, Issue 1, (2012)

Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination., Verheust, Céline, Goossens Martine, Pauwels Katia, and Breyer Didier , Vaccine, 2012 Mar 30, Volume 30, Issue 16, p.2623-32, (2012)

Synthetic Biology. Latest developments, biosafety considerations and regulatory challenges, Pauwels, Katia, Willemarck Nicolas, Breyer Didier, and Herman Philippe , 0/0/2012, Number 43, Brussels, Belgium, p.43, (2012)

De Europese regelgeving inzake GGO's in het licht van nieuwe technieken van genetische modificatie2769, Pauwels, Katia, Breyer Didier, and Herman Philippe , ILVO Nieuwsgolf, 0/0/2010, Volume Sept 2010, (2010)

Methodology of the biological risk classification of animal pathogens in Belgium., Van Vaerenbergh, B, Koenen F., Pauwels Katia, Quanten K, Boyen F, Declercq K, Desmecht D, Thiry J, and Herman Philippe , Rev Sci Tech, 2010 Dec, Volume 29, Issue 3, p.513-22, (2010)

Methodology of the biological risk classification of animal pathogens in Belgium, Van Vaerenbergh, Bernadette, Koenen F., Pauwels Katia, Quanten K., Boyen F., Declercq K., Desmecht D., Thiry J., and Herman Philippe , 0/0/2010, Volume WIV-ISP Scientific Report 2008-2009, Number 140, Brussels, p.5, (2010)

Methodology of the biological risk classification of animal pathogens in Belgium, Van Vaerenbergh, Bernadette, Koenen F., Pauwels Katia, Quanten K., Boyen F., Declercq K., Desmecht D., Thiry J., and Herman Philippe , 0/0/2010, Volume 2008-2009, Number 140, Brussels, p.135 - 140, (2010)

New techniques of genetic modification and the GMO definition, Breyer, Didier, Pauwels Katia, and Herman Philippe , 0/0/2010, Volume WIV-ISP Scientific Report 2008-2009, Number 146, Brussels, p.144 - 146, (2010)

Sampling feasibility study of pathogenic organisms genetically modified or not in contained use activities, Leunda, Amaya, Pauwels Katia, Van Vaerenbergh Bernadette, and Herman Philippe , 0/0/2010, Volume D/2010/2505/19, Number 59, Brussels, p.59, (2010)

Biological risk assessment sheets : Practical examples of risk assessment and biosafety recommendations for the contained use of genetically modified (micro-)organisms, Pauwels, Katia, Van Vaerenbergh Bernadette, Verheust C., and Herman Philippe , 0/0/2009, Volume D/2009/2505/48 , Number 22, Brussels, p.22, (2009)

Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?, Breyer, Didier, Herman Philippe, Brandenburger Annick, Gheysen Godelieve, Remaut Erik, Soumillion Patrice, Van Doorsselaere Jan, Custers René, Pauwels Katia, Sneyers Myriam, et al. , Environ Biosafety Res, 2009 Apr-Jun, Volume 8, Issue 2, p.57-64, (2009)

Inrichtingen met een hoog inperkingsniveau in België. Rapport: Periode 1995-2008, Do Thi, Chuong Dai, Van Vaerenbergh Bernadette, Herman Philippe, Pauwels Katia, Coppens Fanny, Leunda Amaya, and Verheust C. , 0/0/2009, Number 31, Brussels, p.31, (2009)

Les installations de haut niveau de confinement en Belgique. Rapport: Période 1995 - 2008, Do Thi, Chuong Dai, Van Vaerenbergh Bernadette, Herman Philippe, Pauwels Katia, Coppens Fanny, Leunda Amaya, and Verheust C. , 0/0/2009, Number 31, Brussels, p.31, (2009)

Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation, Breyer, Didier, Herman Philippe, Brandenburger A., Gheysen G., Remaut E., Soumillion P., Van Doorsselaere J., Custers R., Pauwels Katia, Sneyers Myriam, et al. , ISB news report, 0/0/2009, Volume November 2009, Number 12, Brussels, p.2 - 12, (2009)

State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations., Pauwels, Katia, Gijsbers Rik, Toelen Jaan, Schambach Axel, Willard-Gallo Karen, Verheust Céline, Debyser Zeger, and Herman Philippe , Curr Gene Ther, 2009 Dec, Volume 9, Issue 6, p.459-74, (2009)

Emploi d'appareils de protection respiratoire durant l'utilisation confinée d'organismes génétiquement modifiés et/ou pathogènes, Pauwels, Katia, Coppens Fanny, Verheust C., Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2008, Volume D/2008/2505/01, Number 27, Brussels, p.27, (2008)

Animal cell cultures: Risk Assessment and biosafety recommendations, Pauwels, Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, Berghmans L., Waeterloos Geneviève, Van Bockstaele D., Dorsch-Hasler K., and Sneyers Myriam , Appl.Biosaf., 0/0/2007, Volume 12, Issue 1, Number 38, p.26 - 38, (2007)

Gebruik van ademhalingsbeschermingsmiddelen bij het ingeperkt gebruik van genetisch gemodificeerde organismen en/of pathogenen, Pauwels, Katia, Coppens Fanny, Verheust C., Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2007, Volume 2007/2505/64, Number 28, Brussels, p.28, (2007)

Biosafety recommendations for the contained use of Mycobacterium tuberculosis complex isolates in industrialized countries, Herman, Philippe, Fauville M., Breyer Didier, Van Vaerenbergh Bernadette, Pauwels Katia, Do Thi Chuong Dai, Sneyers Myriam, Wanlin M., Snacken R., and Moens William , 0/0/2006, Volume D/2006/2505/22, Number 17, Brussels, p.17, (2006)

Bioveiligheidsaanbevelingen aangaande behandelings- en inactiveringsmethoden voor biologisch besmet afval, Berghmans, L., Pauwels Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2006, Volume D/2006/2505/28, Number 33, Brussels, p.33, (2006)

Enceintes de sécurité microbiologique, Herman, Philippe, and Pauwels Katia , 0/0/2006, Volume D/2006/2505/20, Number 15, Brussels, p.15, (2006)

Microbiologische veiligheidswerkkasten, Herman, Philippe, and Pauwels Katia , 0/0/2006, Volume D/2006/2505/20, Number 15, Brussels, p.15, (2006)

Negatieve luchtdruk bij L3 laboratoria, Pauwels, Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, Berghmans L., and Herman Philippe , 0/0/2006, Volume D/2006/2505/15, Number 6, Brussels, p.6, (2006)

Pression de l'air négative dans les laboratoires L3, Pauwels, Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, Berghmans L., and Herman Philippe , 0/0/2006, Volume D/2006/2505/15, Number 6, Brussels, p.6, (2006)

Recommandations de biosécurité relatives au traitement et aux méthodes d'inactivation des déchets biologiques contaminés, Berghmans, L., Pauwels Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2006, Volume D/2006/2505/33, Number 33, Brussels, p.33, (2006)

Opinion on Synthetic Biology III: Risks to the environment and biodiversity related to synthetic biology and research priorities in the field of synthetic biology, Vermeire, T., Epstein M., Hartemann P., Proykova A., Farre Rodriguez, Fernandez Martinez, Chaundhry K, Chandra Rastogi S, Breitling R., Bridges J., et al. , (0)